HIGHLIGHTS
- who: HCL and colleagues from the Department of Clinical Hematology, Charles University, Faculty of Medicine and Teaching Hospital, Hradec Králové, have published the research: RED CELL DISTRIBUTION WIDTH (RDW) AS A MARKER OF DISEASE ACTIVITY IN PATIENTS WITH HAIRY CELL LEUKEMIA (Head: (Head: Summary: Red cell distribution width (RDW) was examined in patients with hairy cell leukemia (HCL) treated with 2chlorodeoxyadenosine (2-CdA) in patients treated with Interferon alpha (IFN-alpha) and in patients subjected to splenectomy, in the Journal: (JOURNAL)
- how: In the first set of the data (17 and 14 subjects) when . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.